CHEST Pulse

Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the Global Initiative for Chronic Obstructive Lung Disease guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more. Since the time of this recording, the US Food and Drug Administration has approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled COPD with type 2 inflammation. This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Primary care providers can play a pivotal role in a patient’s COPD diagnosis by looking out for signs and symptoms and referring patients to pulmonologists when appropriate. In this podcast, Megan Conroy, MD, MEd, FCCP, and Nathan Falk, MD, MBA, CPE, CAQSM, FAAFP, provide pulmonary and primary care perspectives on diagnostic strategies for COPD. This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Early recognition and diagnosis of nontuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Nathan Falk, MD, MBA, and Ashwin Basavaraj, MD, FCCP, as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing. This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.

In this episode, experts discuss the challenges of diagnosing and managing refractory chronic cough—a persistent cough that is often misunderstood and mismanaged. Drawing on findings from a recent CHEST/GSK survey, the conversation highlights gaps in patient evaluation, current treatment barriers, and opportunities to improve care through standardized protocols, better history-taking, and greater awareness of emerging therapies. This podcast is a non-promotional, non-CME educational program brought to you by CHEST in collaboration with GSK.

A man in his late 60s enters a lung cancer screening program and is found to have a 4.5 cm tumor—stage II by size, with high-stakes decisions ahead. The case seems to point toward modern perioperative therapy, until biomarker testing changes everything. In this episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and oncologist Natasha Leighl, MD, to show how multidisciplinary care—and molecular results—can reroute the entire treatment journey. They discuss why nodal staging matters, when perioperative therapy improves outcomes, and how biomarker-driven choices can reshape the safest path, while still leaving room for shared decision-making. Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP Case Guest: Natasha Leighl, MD 

A woman in her early 60s, who never smoked in her lifetime, is diagnosed with stage II lung cancer after an abnormal chest X-ray—and believes surgery has ended the story. But postoperative pathology and molecular testing open a new chapter of therapy designed to lower recurrence risk. In this episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and medical oncologist Natasha Leighl, MD, to unpack how stage II decisions continue long after the operating room. They explore how staging and lymph node assessment shape what comes next; how targeted therapy can fit into survivorship; and how to counsel patients weighing work, travel, side effects, and the emotional whiplash of “I’m cured… unless I’m not.” Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP   Case Guest: Natasha Leighl, MD

A 49-year-old individual who never smoked learns a routine scan has uncovered a suspicious lung lesion—low PET uptake, a negative bronchoscopy, and “stable” imaging… yet clinical instincts say, “Don’t ignore this.” In this story-driven episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and thoracic surgeon Sudish Murthy, MD, PhD, FCCP, to walk through what to do when the data conflict and the stakes are real. Together, they translate the CHEST guideline “guardrails” into bedside decision-making: when surveillance stops being safe, why minimally invasive surgery matters, and how lung-sparing resection can deliver an oncologically sound plan while preserving future options. Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP Case Guest: Sudish Murthy, MD, PhD, FCCP

In the last episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, speaks with Amy E. Morris, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2026 in Phoenix about Exhibit Hall games (last chance to sign up for the escape room!), Experience CHEST, poster presentations, and what to expect at next year's annual meeting in Phoenix, October 18 to 21. The Call for Topics is open now! Submissions are due Tuesday, December 2, at 2 pm CT.

In this episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, and Meredith Turetz, MD, FCCP, Chair of the Training and Transitions Committee, dive into the Network Open Forums at 11:15 am CT (various locations), the Trainee Lounge (South Building, Room 405), and the attendee-favorite CHEST Challenge Championship in the Arie Crown Theater (reception begins at 5 pm, event begins at 6 pm). Support your favorite CHEST Challenge team with just $5 to CHEST philanthropy by voting for your favorite mascot! Whose bovine is best?

In this episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, speaks with Deborah Jo Levine, MD, MS, FCCP, Chair of the Council of Networks, about what not to miss on Monday, including the souvenir T-shirt giveaway in the Exhibit Hall, Section presentations at Experience CHEST, and the Cultures and Communities Reception (6 pm CT, Marriott Marquis, Level 33).

In the first episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, and CHEST President John Howington, MD, MBA, FCCP, welcome you to CHEST 2025 and give a glimpse into the first day of the meeting, including the Opening Session (8 am CT, Arie Crown Theater), the Keynote Address from adventurer and cancer survivor Sean Swarner, and the All-Attendee Welcome Reception (5:30 pm, Marriott Marquis, Grand Horizon ABC).

In this podcast episode, experts explore how relationship-centered communication transforms care in the ICU and other fast-paced clinical environments. Host Susan Corbridge, PhD, ACNP, FCCP, speaks with nurse practitioners Tehya Johnson, MSN, AGPCNC-BC, and Allison Wynes, DNP, FCCP, who share real-world strategies for navigating tough conversations, reducing stigma, and aligning care with patient and family values. Together, they highlight how intentional, compassionate communication fosters trust in high-stakes environments where every moment matters. This CHEST podcast is part of the First 5 Minutes® initiative, dedicated to empowering clinicians to build trust with patients from the very first interaction. Learn more: https://www.chestnet.org/learning-and-events/first-5-minutes 

In this podcast presented by CHEST's Cardiovascular Medicine and Surgery Section, Ross Lavine, MD, interviews David Baran, MD. They explore key topics in cardiogenic shock and mechanical circulatory support and discuss Dr. Baran’s advice for junior faculty and fellows on building a successful career in medicine. 

In this episode, host Doreen Addrizzo-Harris, MD, FCCP, is joined by Amy Springer, MSN, FNP-C, to explore the challenges and treatment strategies for recalcitrant Mycobacterium avium complex (MAC) pulmonary disease, resistant MAC, and Mycobacterium abscessus (M abscessus) infections. They discuss diagnostic considerations, antibiotic resistance, treatment regimens—including US Food and Drug Administration-approved therapies and surgical options—and the critical role of patient compliance. This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. LEARN MORE » This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated. Originally aired: July 1, 2025   HOST Doreen J. Addrizzo-Harris, MD, FCCP  Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine   Director, NYULH Bronchiectasis and NTM Clinical and Translational Program  NYU Grossman School of Medicine  New York, NY  PANELIST Amy Springer, MSN, FNP-C  Senior Nurse Practitioner, NYULH Bronchiectasis and NTM Clinical and Translational Program  Division of Pulmonary, Critical Care, and Sleep Medicine  NYU Langone Health  New York, NY 

In this episode, host Ashwin Basavaraj, MD, FCCP, and guest Charles Daley, MD, discuss bronchiectasis exacerbations. They cover their clinical importance, differentiation from COPD and asthma, and management strategies, including cautious use of steroids. They also discuss prevention methods such as airway clearance, macrolide antibiotics, inhaled antibiotics, and emerging anti-inflammatory therapies in development. This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. LEARN MORE » This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated. Originally aired: July 1, 2025 HOST Ashwin Basavaraj, MD, FCCP  Associate Professor of Medicine  Section Chief, Bellevue Hospital  Associate Director, NYULH Bronchiectasis and NTM Clinical and Translational Program  Division of Pulmonary, Critical Care, and Sleep Medicine   NYU Grossman School of Medicine  New York, NY    PANELIST Charles Daley, MD  Professor, Department of Medicine  Chief, Division of Mycobacterial and Respiratory Infections  National Jewish Health Denver, CO 

In this episode, host Doreen Addrizzo-Harris, MD, FCCP, is joined by Keren Bakal, MD, and Amy Springer, MSN, FNP-C, to explore initial treatment strategies for bronchiectasis and nontuberculous mycobacteria (NTM) pulmonary disease. The conversation delves into the critical role of airway clearance therapy, challenges in selecting individualized treatments, and the importance of patient education. The experts also discuss the latest guidelines for managing nodular and cavitary NTM lung disease, including when to initiate treatment vs monitoring, as well as strategies for managing common drug toxicities. Additionally, they examine comorbidities often seen in patients with bronchiectasis, such as gastrointestinal disorders, sinus disease, and psychosocial factors like anxiety and depression. This episode is part of CHEST's Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. LEARN MORE » This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.   HOST Doreen J. Addrizzo-Harris, MD, FCCP Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine  Director, NYULH Bronchiectasis and NTM Clinical and Translational Program NYU Grossman School of Medicine New York, NY   PANELISTS Keren Bakal, MD Clinical Attending, Pulmonary and Critical Care Medicine Overlook Medical Center/Atlantic Health System Summit Health Livingston, NJ   Amy Springer, MSN, FNP-C Senior Nurse Practitioner NYULH Bronchiectasis and NTM Clinical and Translational Program  Division of Pulmonary, Critical Care, and Sleep Medicine  NYU Langone Health  New York, NY 

In this episode, experts discuss how clinicians can address vaccine hesitancy in their patients, especially those with chronic respiratory conditions. This episode explores communication strategies, key factors shaping vaccine acceptance, and best practices for health care providers. Learn practical ways to build trust using CHEST’s First 5 Minutes® strategies, and support patients in making informed vaccination decisions to protect against severe respiratory illnesses like RSV, COVID-19, and influenza. Moderator Ryan Maves, MD, FCCP Panelist Megan Conroy, MD, MA(Ed), FCCP

In this episode of CHEST Morning Preview, Gabriel Bosslet, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2024, previews the final day of CHEST 2024 while speaking with Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, about what to expect from next year’s meeting in Chicago. Submit a session proposal for CHEST 2025 »    

In this episode of CHEST Morning Preview, Gabriel Bosslet, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2024, speaks with Training and Transitions Committee Chair, Subani Chandra, MD, FCCP, about what to expect from the conference on Tuesday, including the Network Open Forums (11:15 am ET), opportunities for trainees, and the highly anticipated CHEST Challenge Championship (doors open at 7:30 pm ET).

In this episode of CHEST Morning Preview, Gabriel Bosslet, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2024, speaks with Council of Networks Chair, Margaret Pisani, MD, MPH, FCCP, about what not to miss on Monday, including the Women in Chest Medicine Luncheon (12 pm ET, preregistration required) and the Network Mixer (5 pm ET).